Viewing Study NCT05770466


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2025-12-28 @ 8:38 AM
Study NCT ID: NCT05770466
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2022-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.
Sponsor: National Taiwan University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module